Submit an Article
Online ISSN: 1945-4589
Impact Journals, LLC. is the publisher of Aging: www.impactjournals.com.
Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.
Impact Journals is a member of the Society for Scholarly Publishing.
Learn about our FREE Post-Publication Promotion Services
Commentaries and Editorials Volume 3, Issue 4 pp 348—362

Gerosuppressant Metformin: less is more

Javier A. Menendez1,2, , Sílvia Cufí1,2, , Cristina Oliveras-Ferraros1,2, , Luciano Vellon3, , Jorge Joven4, , Alejandro Vazquez-Martin1,2, ,

  • 1 Catalan Institute of Oncology, Girona (Catalonia, Spain)
  • 2 Girona Biomedical Research Institute, Girona (Catalonia, Spain)
  • 3 Fundación INBIOMED, Cell Reprogramming Unit, San Sebastián (Basque Country, Spain)
  • 4 Centre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d'Investigaciò Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Catalonia, Spain)

Received: March 27, 2011       Published: April 4, 2011      

https://doi.org/10.18632/aging.100316
How to Cite

Copyright: © 2011 Menendez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF
Corresponding Author

Javier A. Menendez
jmenendez@iconcologia.net

Related Article

Commentary on: If started early in life, metformin treatment increases life span and postpone tumors in female SHR mice. [PubMed]